Investigation of molecular pathways demonstrates that inhibition of ROS-mediated GC progression is induced by down-regulation of c-Jun and ERK1/2 phosphorylation through MEK1/2 [148]. This evidence concerns the gene MAP2K1 and gastric cancer.